Kristin A. Caltrider - 28 Feb 2023 Form 4 Insider Report for Inogen Inc (INGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2023, 19:35:45 UTC
Prior SEC filing
12 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leslyn Cicekli, as Attorney-in-Fact

Key filing fact

Kristin A. Caltrider filed Form 4 for Inogen Inc (INGN) on 02 Mar 2023.

Key facts

  • This page summarizes Kristin A. Caltrider's Form 4 filing for Inogen Inc (INGN).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2023, 19:35.

Change

  • Previous filing in this sequence was filed on 12 May 2022.
  • Current net transaction value: -$96,954.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+11,360
Change %
Price
$0.000000
Shares after
11,360
Date
01 Mar 2023
Ownership
Direct
INGN transaction

Common Stock

Tax liability

Transaction value
$96,954
Shares
-6,231
Change %
-55%
Price
$15.56
Shares after
5,129
Date
01 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-11,360
Change %
-33%
Price
$0.000000
Shares after
22,721
Date
01 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,360
Exercise price
Footnotes
F2, F3
INGN transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+28,079
Change %
Price
$0.000000
Shares after
28,079
Date
28 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
28,079
Exercise price
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F3

Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023 and 1/3rd of the restricted units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Footnote F4

Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024 and 1/3rd of the restricted units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .